Offer for Subscription - Update

RNS Number : 0892D
Baronsmead Venture Trust PLC
28 February 2022
 

 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA,  THE UNITED STATES OR ANY MEMBER STATE OF THE EEA (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY MARKETED), OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO ISSUE OR SELL, OR ANY SOLICITATION OF ANY OFFER TO SUBSCRIBE OR PURCHASE, ANY INVESTMENTS IN ANY JURISDICTION.

 

Baronsmead Venture Trust plc

 

LEI: 213800VQ1PQHOJXDDQ88

 

28 February 2022

 

Offer for Subscription - Update

The Board of Baronsmead Venture Trust plc announced on 15 February 2022 that its offer for subscription to raise up to £25 million with an over-allotment facility to raise up to a further £12.5 million (the "Offer") was closed and that no further subscriptions for new shares were being accepted.

On 28 February 2022, Baronsmead Second Venture Trust plc announced that its offer for subscription was also closed.

The Board advises that it is intended that the fourth and final allotment of shares under the Offer is expected to be in the week commencing 7 March 2022.

For further information please contact:

 

Baronsmead VCT Investor Relations

020 7382 0999 baronsmeadvcts@greshamhouse.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAKAPASPAEFA
UK 100

Latest directors dealings